Boston Biopharma focuses on therapeutic areas that impact the lives of hundreds of millions worldwide, we are always seeking better ways to provide high quality cost effective medications to people living with serious medical conditions. It’s what drives us forward and inspires us to stay the course in challenging therapeutic areas.
Boston Biopharma has been focusing on generic pharmaceuticals since 2003, with 12 sophisticated oncology products successfully launched, with additional products in the pipeline.
We deliver our medications via two strategies:
- Providing high-quality products co-developed by Boston Biopharma and partners; and
- Providing royalty-based know-how to locally produce high quality medications.
Our business development efforts are led by a multi-disciplinary team with significant pharmaceutical and regional expertise. We believe our current product portfolio is representative not only of our discriminating efforts but also of the types of opportunities we seek.
These efforts allow Boston Biopharma to selectively build a portfolio of differentiated, safe, and effective products for underserved patient populations.
Achieving Quality and Excellence
Our dedication to quality in everything we do is uncompromising, and covers every stage of the development, production, and administration of our medicines.